^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

DEK-AFF2 fusion

i
Other names: DEK, DEK Proto-Oncogene, DEK Oncogene, Protein DEK, MRX2, Protein Ox19, FRAXE, Fragile X Mental Retardation 2, FMR2, OX19, FMR2P, Protein FMR-2, Fragile X Mental Retardation 2 Protein, AFF2, AF4/FMR2 Family Member 2, Fragile X E Mental Retardation Syndrome Protein
Entrez ID:
Related biomarkers:
13d
Journal
|
AFF2 (AF4/FMR2 family member 2)
|
DEK-AFF2 fusion
2ms
DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity. (PubMed, Head Neck Pathol)
This study highlights that AFF2 IHC can be an invaluable surrogate marker to FISH in identifying DEK::AFF2 SCC in challenging cases to avoid misdiagnosis. Detailed clinical and pathologic data were collected to gain a better understanding of this emerging challenging entity. A literature review was performed to enrich our knowledge of DEK::AFF2 SCC.
Retrospective data • Review • Journal
|
EGFR (Epidermal growth factor receptor) • KRAS (KRAS proto-oncogene GTPase) • AFF2 (AF4/FMR2 family member 2)
|
KRAS mutation • EGFR mutation • DEK-AFF2 fusion
12ms
Prevalence and interpretation of AFF immunostain of DEK::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas. (PubMed, Virchows Arch)
Granular, cytoplasmic, or incomplete AFF staining should be considered as negative. In view of the rarity of DEK::AFF2 carcinomas, plasma cells and plasma cell neoplasms are potential for internal and surrogate external controls.
Retrospective data • Journal
|
AFF2 (AF4/FMR2 family member 2) • DEK (DEK Proto-Oncogene)
|
DEK-AFF2 fusion
1year
The First Report of Cytology of DEK::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma on Fine-Needle Aspiration. (PubMed, Head Neck Pathol)
Our finding suggests that in nodal aspirates of patients with a history of sinonasal-type papillomas, especially those with prior malignant transformation or atypia, there should be consideration for the possibility of DEK::AFF2-related primary. When in doubt, DEK FISH of AFF2 immunohistochemistry should be performed for confirmation.
Journal • Cytology
|
AFF2 (AF4/FMR2 family member 2)
|
DEK-AFF2 fusion
1year
Journal
|
AFF2 (AF4/FMR2 family member 2)
|
DEK-AFF2 fusion
over1year
Sinonasal Adenosquamous Carcinoma - Morphology and Genetic Drivers Including Low- and High-Risk Human Papillomavirus mRNA, DEK::AFF2 Fusion, and MAML2 Rearrangement. (PubMed, Head Neck Pathol)
Sinonasal adenosquamous carcinoma is a somewhat heterogeneous tumor not infrequently arising ex papilloma and having various drivers including high- and low-risk HPV and rarely DEK::AFF2 fusion. The prognosis appears favorable when proper treatment is possible.
Journal
|
AFF2 (AF4/FMR2 family member 2) • MAML2 (Mastermind Like Transcriptional Coactivator 2)
|
CDKN2A negative • DEK-AFF2 fusion
2years
DEK::AFF2 Fusion Carcinomas of Head and Neck. (PubMed, Adv Anat Pathol)
This tumor behaves aggressively involving adjacent vital structures, frequently recurs, and is inclined to develop lymph node and distant metastasis. This review aims to summarize the demographic, clinical, pathologic, immunophenotypic features, and pattern of molecular alterations as well as to discuss the differential diagnosis of DEK::AFF2 fusion carcinoma.
Journal
|
AFF2 (AF4/FMR2 family member 2)
|
DEK-AFF2 fusion